FunPep

Announcing the Start of Administration of Functional Peptide SR-0379 to Subjects in Phase III Clinical Trial

FunPep Signs Joint Research Agreement for a Next-generation Drug Formulation Technology for Antibody Inducing Peptides Using Microneedle Array Patch

Announcing the Start of Phase III Clinical Trials for Functional Peptide SR-0379

Submission of Clinical Trial Plan for a Phase III Clinical Trial of Functional Peptide SR-0379

Announcement of Newly Developed Antibody-inducing Peptide Compound